Case number: 1:12-bk-12942 - Pangea Biosciences, Inc. - Delaware Bankruptcy Court

Case Information
  • Case title

    Pangea Biosciences, Inc.

  • Court

    Delaware (debke)

  • Chapter

    11

  • Filed

    10/26/2012

  • Last Filing

    12/20/2012

  • Asset

    Yes

Docket Header
VerifDue, PlnDue, DsclsDue



U.S. Bankruptcy Court
District of Delaware (Delaware)
Bankruptcy Petition #: 12-12942-PJW

Assigned to: Peter J. Walsh
Chapter 11
Voluntary
Asset

Date filed:  10/26/2012

Debtor

Pangea Biosciences, Inc.

1104 Rodman Street
Philadelphia, PA 19147
PHILADELPHIA-PA
Tax ID / EIN: 46-1275257

represented by
Ryan M. Ernst

O'Kelly Ernst Bielli & Wallen, LLC
901 N. Market Street
Suite 1000
Wilmington, DE 19801
302-778-4000
Fax : 302-295-2873
Email: rernst@oebwlegal.com

Thomas D. Bielli

O'Kelly Ernst Bielli & Whalen, LLC
1600 Market Street
25th Floor
Philadelphia, PA 19103
215-543-7182
Fax : 215-391-4350
Email: tbielli@oebwlegal.com

U.S. Trustee

United States Trustee

844 King Street, Room 2207
Lockbox #35
Wilmington, DE 19899-0035
302-573-6491
 
 

Latest Dockets

Date Filed#Docket Text
10/27/2012Judge Peter J. Walsh added to case. (LA) (Entered: 10/27/2012)
10/26/20125Notice of Appearance Filed by Pangea Biosciences, Inc.. (Bielli, Thomas) (Entered: 10/26/2012)
10/26/20124Motion to Appear pro hac vice-- Motion and Order for Admission Pro Hac Vice of Thomas D. Bielli, Esquire, of O'Kelly Ernst & Bielli, LLC --. Receipt Number 14352, Filed by Pangea Biosciences, Inc.. (Ernst, Ryan) (Entered: 10/26/2012)
10/26/20123Exhibit(s)-- Corporate Resolution -- Resolution of Pangea Biosciences, Inc., a Delaware Corporation, Authorizing Filing of Petition for Reorganization --(related document(s) 1) Filed by Pangea Biosciences, Inc.. (Ernst, Ryan) (Entered: 10/26/2012)
10/26/20122Receipt of filing fee for Voluntary Petition (Chapter 11)(12-12942) [misc,volp11a] (1046.00). Receipt Number 6240454, amount $1046.00. (U.S. Treasury) (Entered: 10/26/2012)
10/26/20121Chapter 11 Voluntary Petition. Fee Amount $1046. Filed by Pangea Biosciences, Inc.. (Ernst, Ryan) (Entered: 10/26/2012)